Loading
OT
Origin Therapeutics Holdings Inc. (formerly, 1278700 B.C. Ltd.) Stock: price and insider trades · Canada
Origin Therapeutics Holdings Inc. (formerly, 1278700 B.C. Ltd.): what insiders have been doing
Origin Therapeutics Holdings Inc. (formerly, 1278700 B.C. Ltd.) has a thin disclosure history in our data (latest filing: 16 September 2022). New filings will appear here as soon as they are published. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
7
Thresholds
n/a
Buy Volume
€1,853
1 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 16 September 2022
Declarations7 total
Common SharesTSXSEDI:4003107
Common SharesTSXSEDI:4003106
25,000 shares@ CA$0.10100.0% of flowCommon SharesTSXSEDI:3960473
Canonical exit: 8 Sept 2022 (T+90)
Common SharesTSXSEDI:3946800
Common SharesTSXSEDI:3946661
Common SharesTSXSEDI:3946805
Common SharesTSXSEDI:3946832
7 of 7 declarations
About Origin Therapeutics Holdings Inc. (formerly, 1278700 B.C. Ltd.)
Origin Therapeutics Holdings Inc. is a biotechnology company focused on developing innovative therapies. It was previously known as 1278700 B.C. Ltd.
